<DOC>
	<DOC>NCT01041183</DOC>
	<brief_summary>Patients undergoing general anesthesia for laparoscopic cholecystectomy have a high risk of postoperative nausea and vomiting (PONV). The investigators investigated the effect of oral and IV ramosetron on PONV prophylaxis after laparoscopic cholecystectomy.</brief_summary>
	<brief_title>The Effect of Oral and Intravenous Ramosetron During Laparoscopic Cholecystectomy</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<criteria>ASA III patients, 2565 years, electivelaparoscopic cholecystectomy under general anesthesia GI disease, pregnant or menstruating, history of motion sickness and/or postoperative emesis, antiemetics within 24 h before surgery</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Oral plus IV ramosetron may be more effective than</keyword>
	<keyword>IV ramosetron and oral ramosetron for the prophylaxis of</keyword>
	<keyword>PONV after laparoscopic cholecystectomy</keyword>
</DOC>